Brazil’s Countrywide Well being Surveillance Company (Anvisa) on Friday authorized the importation of monkeypox vaccines and medications that have not nonetheless been registered in the state on an “outstanding and temporary foundation”.
The collegiate administration of the regulatory human body unanimously resolved to approve the rule to “speed up the population’s access to vaccines and medicines” in opposition to monkeypox, which, according to the most up-to-date bulletin of the Ministry of Health, registered 3,450 confirmed cases up to 18 August and 4,491 below examination.
–